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Abstract
The proinflammatory cytokine TNFa fails to provoke cell death in isolated hepatocytes but has been implicated in
hepatocyte apoptosis during liver diseases associated with chronic inflammation. Recently, we showed that TNFa is able to
sensitize primary murine hepatocytes cultured on collagen to Fas ligand-induced apoptosis and presented a mathematical
model of the sensitizing effect. Here, we analyze how TNFa induces apoptosis in combination with the transcriptional
inhibitor actinomycin D (ActD). Accumulation of reactive oxygen species (ROS) in response to TNFR activation turns out to
be critical for sustained activation of JNK which then triggers mitochondrial pathway-dependent apoptosis. In addition, the
amount of JNK is strongly upregulated in a ROS-dependent way. In contrast to TNFa plus cycloheximide no cFLIP
degradation is observed suggesting a different apoptosis pathway in which the Itch-mediated cFLIP degradation and
predominantly caspase-8 activation is not involved. Time-resolved data of the respective pro- and antiapoptotic factors are
obtained and subjected to mathematical modeling. On the basis of these data we developed a mathematical model which
reproduces the complex interplay regulating the phosphorylation status of JNK and generation of ROS. This model was fully
integrated with our model of TNFa/Fas ligand sensitizing as well as with a published NF-kB-model. The resulting
comprehensive model delivers insight in the dynamical interplay between the TNFa and FasL pathways, NF-kB and ROS and
gives an example for successful model integration.
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Introduction
Hepatocyte apoptosis is associated with many acute and chronic
liver diseases. Regulation of the apoptotic process is complex and
mainly triggered through the activation of so-called death
receptors [1]. Among these, the tumor necrosis factor (TNF)-
receptor-1 and its ligand TNFa play a crucial role [2]. Upon
binding of TNFa to TNFR1, a membrane bound complex I
consisting of TNFR1, RIP-1, TRAF2 and TRADD is first formed
which rapidly activates the survival transcription factor NF-kB and
the c-Jun N-terminal kinase (JNK) [3]. NF-kB activation is the
main reason why TNFa alone does not primarily lead to
hepatocyte apoptosis. However, to signal for cell death, a second,
receptor-free complex II has to assemble in the cytoplasm which
still contains RIP1, TRAF2 and TRADD but recruits FADD and
procaspase-8 [3]. TNFR1 activation alone only induces a weak
and transient formation of complex II [2]. At complex II
procaspase-8 is activated by autocatalytic cleavage [4]. Active
caspase-8 can then trigger two different apoptotic signaling
pathways. In the so-called type I cells, active caspase-8 directly
cleaves and activates procaspase-3 to induce efficient cell death
execution. In so-called type II cells, caspase-8 preferentially
processes the BH3-only protein Bid into its truncated form tBid.
tBid belongs to the subclass of BH3-only Bcl-2 family members
such as Bim, Puma, Noxa, which sense apoptotic stimuli and
convey the death signals to Bax/Bak activation on mitochondria
[5]. Bax/Bak are essential for mitochondrial membrane permea-
bilisation (MOMP) and the release of apoptogenic factors such as
cytochrome c. Cytochrome c finally activates the Apaf-1/caspase-
9 apoptosome resulting in effector caspase-3/-7 activation and cell
death execution. However, it has been shown that Bid-indepen-
dent pathways can also lead to mitochondrial activation [6].
Recently, a study demonstrated that besides Bid the BH3-only
protein Bim is also essential for TNFa-induced apoptosis in
hepatocytes [7].
While the initiation of apoptosis by the receptor complex and
the execution via the mitochondrial pathway constitute two parts
of the machinery, several other pathways affect the apoptotic
process dramatically. Among these, the JNK pathway deserves
special interest. JNK is a serine/threonine protein MAPK which is
known to be rapidly activated by TNFa complex I via the MAPK
kinase MKK7 [8,9]. This transient activation is normally
terminated by MAPK phosphatases (MKPs) within 60 minutes,
a mechanism itself controlled by NF-kB survival signaling [10].
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activation of JNK which causes apoptosis [11]. To induce
sustained JNK activation, the termination mechanism of the
JNK activity is deranged, namely the MKPs are inhibited by
reactive oxygen species (ROS). TNFa-induced ROS accumulate
as soon as they are no longer suppressed by antioxidant enzymes,
such as superoxide dismutases (SODs), glutathione peroxidase or
ferritin, and can then cause oxidation and inhibition of MKPs
[10,12]. When, under the explained conditions, ROS induce a
prolonged activation of JNK, several mechanisms linking this
pathway to cell death execution have been proposed. It has been
reported that JNK directly activates the E3 ubiquitin ligase Itch
which induces proteasomal processing of cFLIP [13]. cFLIP
specifically inhibits caspase-8 by interacting with FADD, therefore
preventing the activation of procaspase-8 at complex II as well as
at the DISC [14]. If cFLIP is degraded by JNK and Itch, complex
II can recruit procaspase-8 and execute the apoptotic process as
described above. Furthermore, it has been proposed that JNK can
directly activate the mitochondrial pathway. While it has been
suggested that JNK generates the proapoptotic Bid cleavage
product jBid [15] several other reports indicate that JNK activates
the BH3-only protein Bim [7,16]. Both Bid and Bim can then
activate the mitochondrial apoptosis pathway.
As mentioned above, TNFa alone does not lead to cell death
and this is due to its strong NF-kB activating properties. NF-kB
survival signaling interferes with the TNF pathway at various
levels to prevent apoptosis. Hereby, the antiapoptotic activity of
NF-kB mainly depends on gene induction, namely the transcrip-
tional regulation of survival genes [17]. Among these, the caspase
inhibitors cFLIP and XIAP as well as the inhibitor of apoptosis
proteins, cIAP1 and 2 and the Bcl-2 family proteins are well
known to be upregulated by NF-kB in several cell types [4,18].
However, these antiapoptotic proteins alone cannot fully protect
the cells from apoptosis. Thus, another NF-kB-dependent
mechanism has been suggested such as the prevention of ROS
accumulation [12]. In contrast, it was shown that the proapoptotic
effects of JNK do not require transcription and that JNK1
activates a mitochondrial death pathway [19]. Taken together,
apoptosis induction by TNFa is regulated by a complex network of
signaling pathways and understanding these processes requires a
holistic approach which integrates all levels of the network.
Accordingly, mathematical modeling also needs to integrate the
different levels of the network to describe the biological process
properly and thereby allow reliable predictions.
In this study, we introduce a mathematical model for TNFa-
induced apoptosis in hepatocytes which is based on presented
measurement results and literature data. The developed model is
connected with a TNFa/Fas ligand sensitizing model [20] and
with an NF-kB model [21] to reflect the complex crosstalks in this
system. The final comprehensive model covers the sensitizing
effect of TNFa towards FasL-induced apoptosis as well as
apoptosis after TNFa plus ActD or plus cycloheximide, respec-
tively, and gives an important example for successful model
integration. All models employed in this study are based on
ordinary differential equations (ODEs) and mass action kinetics.
[20,22]
Materials and Methods
Mice
Wild-type mice were purchased from Jackson Laboratories.
Bid2/2 mice and XIAP2/2 were generously provided by
Andreas Strasser and John Silke, WEHI, Melbourne, respectively.
All mice were bred on the C57BL/6 background for several
generations. Hepatocyte isolation from these mice was approved
by the animal experimental committees and animals were handled
and housed according to specific pathogen free (SPF) conditions.
Isolation and cultivation of primary mouse hepatocytes
Primary hepatocytes were isolated from 8–12 week old B6
(C57Bl/6NNrl) mice using the collagenase perfusion technique as
previously described [23].
Preparation of cytosolic and mitochondrial lysates
Crude mitochondrial and cytosolic fractions were prepared as
described before [22]. Briefly, 6610
6 detached hepatocytes were
resuspended in SEM buffer (10 mM Hepes-KOH and 250 mM
sucrose) containing protease inhibitors as described above and
homogenized in a Dounce homogenizer. The nuclei were
removed by centrifugation at 5006g, and crude mitochondria
were obtained from the supernatant by an additional centrifuga-
tion step at 10’0006g. Mitochondria were washed twice in SEM
buffer and then solubilized in H8 buffer (20 mM Tris-HCl,
pH 7.5, 2 mM EDTA, 2 mM EGTA, 6 mM ß-mercaptoethanol)
containing 1% SDS. All fractions were used for Western Blot
analyses; cytosolic fractions were also used for cytochrome c
detection by ELISA.
DEVDase assay
The activity of the executioner caspases-3/-7 was measured by
the fluorogenic DEVDase assay. Briefly, 1610
6 primary mouse
hepatocytes were incubated with TNFa (R&D Systems) or
actinomycin D (ActD) (Alexis) at different doses for the indicated
times. Then the cell suspension was centrifuged, washed with PBS
and homogenized in 50 ml homogenization buffer (30 mM Hepes-
KOH, 2.5 mM MgCl2, 2.5 mM EGTA, 12 mM DTT supple-
mented with the protease inhibitors 12 mg/ml aprotinin, 12 mg/ml
leupeptin, 0.5 mg/ml pepstatin, 0.125 mM PMSF, 1.5 mg/ml
cytochalasin B). The caspase-3/-7 activity assay was performed
exactly as described in [24] using the caspase-3 substrate DEVD-
AMC (Alexis) at a concentration of 200 nM. Relative fluorescence
units (RFU) values were calculated via the ratio of average rate of
the fluorescence increase and protein concentration determined by
Bradford assay (Biorad). To compare different experiments, RFU
sample values were referred to negative control (untreated cells).
Western blotting
50–70 mg of total protein was separated by SDS-PAGE (12%,
15% or 17,5% gels) and transferred to a 0.45 mm or 0.2 mm pore
size PVDF membrane (Roche Applied Science and BioRad,
respectively). The respective antigens were detected by antibodies
against phospho-JNK at 1:1000 (Cell Signaling), JNK at 1:1000
(Cell Signaling), b-actin at 1:10000 (MP Biomedicals) cFLIPL/S
and cFLIPL both at 1:1000 (Santa Cruz Biotechnology) and
MnSOD at 1:5000 (R&D Systems) followed by the respective
horseradish peroxidase-labeled secondary antibodies (Jackson
ImmunoResearch Laboratories or Cell Signaling), and the ECL
plus chemiluminescence detection reagent (Amersham Bioscienc-
es). Chemiluminescent images were quantified using the LumiI-
mager and the LumiAnalyst Software (Roche Applied Science).
RNA isolation, cDNA synthesis and qRT-PCR
Total RNA was isolated using the RNeasy Plus Kit of Qiagen,
according to the manufacturer’s directions. The quantity and
purity of RNA was determined by measuring the optical density at
260 and 280 nm. Subsequently, 1 mg of total RNA was converted
to single strand cDNA using Quantiscript Reverse Transcriptase
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performed with multiplex quantitative real time PCR. In a 25 ml
PCR reaction, 2 ml of cDNA (corresponding to 20 ng of total
RNA input) was amplified in an Light Cycler 480 (Roche) using 2-
fold QuantiTect Multiplex PCR Master Mix (Qiagen), 50 nM
primers and 100 nM probe for the 18S rRNA reference gene (fwd:
59-CGGCTACCACATCCAAGG-39, rev: 59-CGGGTCGGGA-
GTGGGT, probe: 59-TTGCGCGCCTGCTGCCT), and 300 nM
primers and 100 nM probe for the gene of interest. The following
target gene primers and probes were used (all from Sigma
Genosys): mouse cFLIP (fwd: 59-TGCCAGAGTGTGGAGAA-
CAG-39; rev: 59-TTACCCAGTCGCATGACAAA-39; probe: 59-
GGGGGAGGTTATCTACCAAGT-39) and mouse MnSOD
(fwd: 59- CCCTTAGGGCTCAGGTTTGTC-39, rev: 59-GCC-
ACCGAGGAGAAGTACC-39, probe: 59- AGATGTTACAA-
CTCAGGTCGCTCTTCAG-39). The mRNA level for the gene
of interest was determined as 2-DDCT and reflects changes
relative to untreated cells.
Cytochrome c ELISA
To quantify the amount of cytochrome c in subcellular fractions
an ELISA kit from R&D Systems was applied. From 6610
6
hepatocytes cytosolic fractions were obtained as described above
and ELISA performed according to the manufacturer’s instruc-
tions. Briefly, 1:50 dilutions from cytosolic fractions and
corresponding standards were analyzed and absorbance measured
at 450 nm. Cytochrome c concentrations were calculated using
the standard concentration curve.
Measurement of reactive oxygen species by
dichlorofluorescin fluorescence assay
ROS produced by the different treatments with TNFa (R&D
Systems), ActD (Alexis) or butylhydroxyanisol (BHA) (Sigma) were
assessed by the oxidation-sensitive probe 2, 7-dichloro-dihydrofluor-
escin diacetate (H2DCFDA, Sigma). H2DCFDA diffuses easily
across the cell membrane and is then trapped in the cell by
deacetylation. In the presence of ROS,H2DCF israpidlyoxidized to
the highly fluorescent compound dichlorofluorescin (DCF) [25].
Briefly, 1610
6 primary mouse hepatocytes were incubated with
TNFa,ActDorBHAfortheindicatedtimesand H2DCFDA 20 mM
was added in the last 20 minutes of incubation. After centrifugation
at21506g,4uCfor 3 min,washing withPBS,anothercentrifugation
cells were lysed in 70 ml lysis buffer (20 mM Tris/HCl pH 7.4,
136 mM NaCl, 2 mM EDTA, 10% glycerol, 4 mM benzamidine,
50 mM b-glycerophosphate, 20 mM Na-diphosphate, 10 mM NaF,
1m MN a 3VO4, 1% Triton X-100 supplemented with the protease
inhibitors 5 mg/ml aprotinin, 5 mg/ml leupeptin, 0.2 mM AEBSF)
by shaking at 4uC for 20 min followed by a final centrifugation at
20’8006g, 4uC for 10 min. 10 ml of cell lysate was diluted with 90 ml
of assay buffer (100 mM HEPES-KOH supplemented with
100 mM DTT) in a 96-well plate and fluorescence was determined
using an excitation wavelength of 485 nm and emission of 540 nm.
To quantify fluorescence a DCF standard curve was measured and
calculated as described before [26] and sample values determined as
fold increase referred to untreated control.
Other experimental procedures
Other experimental procedures are described in detail in the
Supplementary Information S1. These include detailed description
of the isolation and cultivation of primary murine hepatocytes,
cultivation of 3T9 mouse embryonic fibroblasts (MEFs), prepara-
tion of total and nuclear extracts and electrophoretic mobility shift
assay (EMSA).
Results
TNFa induces apoptosis via type II extrinsic pathway but
only in the presence of a transcription inhibitor
In order to characterize the TNF apoptosis pathway in
hepatocytes, we first examined the dynamics of effector caspase-
3 activation. While TNFa alone does not activate caspase-3,
hepatocytes pretreated with the transcription inhibitor ActD
show a remarkable increase in caspase-3/-7 activity within 5–
10 h of treatment (Figure 1A), consistent with previously
reported results [19]. Caspase-3/-7 activation resulted in cell
death as we have previously reported [22] and therefore reflects
a measure for apoptosis quantification. Furthermore, we have
demonstrated before in hepatocytes from Bid
2/2 mice that
TNFa-induced apoptosis is clearly dependent on the BH3-only
protein Bid indicating that apoptosis occurs via type II pathway.
We substantiated this observation by demonstrating that loss of
the caspase-3 and -9 inhibitor XIAP does not further enhance
cell death after TNFa and ActD treatment [22]. In the type II
apoptosis pathway XIAP is neutralized by Smac/DIABLO
which is released from the mitochondria. Therefore, loss of
XIAP does not lead to any further increase of caspase-3
activation as it is observed in type I pathway. Accordingly,
XIAP
2/2 hepatocytes did not reveal an increased caspase-3
activity after TNF-a and ActD treatment compared to wt
hepatocytes [22]. To confirm that TNFa induces apoptosis via
type II pathway we investigated another downstream event of
mitochondria activation which is cytochrome c release to the
cytosol. Indeed, we found cytochrome c to be released from the
mitochondria in a time-dependent manner as shown in
Figure 1B. The above described results clearly show that TNFa
induces type II apoptosis pathway via the proteins Bid and
cytochrome c in the presence of the transcription inhibitor
ActD.
ROS accumulate upon TNFa treatment and mediate
mitochondria-dependent cell death
Since oxidative burst has been implicated in apoptosis under
several circumstances, we investigated ROS accumulation upon
TNFa treatment. Again, TNFa alone did not induce any
significant increase in intracellular ROS amounts. Interestingly,
the cells showed elevated ROS levels after 5 hours of TNFa and
ActD treatment remaining on that level over the whole incubation
time investigated (Figure 2A). Consequently, preincubation of
primary murine hepatocytes with the antioxidant butylhydrox-
yanisol (BHA) before TNFa and ActD challenge reduced ROS to
the level of untreated control cells (Figure 2B). Note, that basal
ROS were also reduced by BHA. Furthermore, we investigated if
the observed ROS accumulation plays a critical role in TNFa
mediated apoptosis. Therefore, primary murine hepatocytes were
again preincubated with BHA and apoptosis was monitored by
measuring capase-3/-7 activation. Indeed, the presence of an
antioxidant which neutralizes ROS (Figure 2B) rendered the cells
completely from apoptosis as shown in Figure 2C. Interestingly,
BHA also prevented TNFa and ActD-induced cytochrome c
release from the mitochondria (Figure 1B). This indicates that
ROS are responsible for cytochrome c release during mitochon-
dria-dependent apoptosis.
Sustained JNK activation due to ROS accumulation is
critical for apoptosis induction
ROS are known to modulate the activity of the TNF receptor
activated kinase JNK. Since we observed that ROS mediate cell
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JNK by Western Blotting of the active form phospho-JNK. As
expected, JNK was slightly activated by TNFa alone and in
combination with ActD in the first 30 minutes (Figure 3A and
3B) concomitant with previously reported results [20]. Notably,
TNFa and ActD strongly induced sustained JNK activation at
6–8 h of incubation (Figure 3B) which is exactly the time when
maximal caspase activation can be observed. Underlining the
relevance of this sustained JNK activation for apoptosis, it
turned out to be sensitive to antioxidants. The antioxidant BHA
effectively prevented the later formation of pJNK as shown in
Figure 3C. Astonishingly, TNFa and ActD treatment strongly
upregulated the amount of JNK protein (Figure 3B) which did
not occur with TNFa alone (Figure 3A) and was prevented by
the antioxidant BHA (Figure 3C). This suggests that TNFa and
ActD induce sustained phosphorylation of JNK at least in part
by upregulating the inactive, unphosphorylated form JNK and
that ROS mediate this upregulation. To finally substantiate the
role of JNK in TNFa-mediated apoptosis, we investigated the
influence of JNK inhibition on caspase-3/-7 activation.
Preincubation of hepatocytes with the JNK inhibitor
SP600125 strongly reduced caspase-3/-7 activity and protected
the cells from cell death (Figure 3D) which is in accordance
with [19]. In addition, TNFa plus ActD-mediated caspase
activation could be further elevated by additional incubation
with the death receptor ligand Fas. Together with previous
observations, these findings indicate the direct involvement of
ROS-mediated sustained JNK activation in apoptosis induction
by TNFa plus ActD.
Figure 1. TNFa and ActD induce strong caspase-3/-7 activation
and antioxidant-sensitive cytochrome c release in primary
hepatocytes. (A) Caspase-3/-7 activity determined by fluorogenic
DEVDase assay of primary murine hepatocytes treated with TNFa
(25 ng/ml), ActD (0.4 mg/ml) or TNFa+ActD. (B) Cytochrome c
concentration determined by ELISA in the cytosol of hepatocytes after
treatment with TNFa or TNFa+ActD in the presence or absence of the
antioxidant BHA (100 mM) for the indicated times. Means of at least
three independent experiments 6 s.d. are shown (** P,0.01, # P,0.05
both versus TNFa-treated cells, Student’s t-test).
doi:10.1371/journal.pone.0018646.g001
Figure 2. TNFa plus ActD induce antioxidant-sensitive
ROS accumulation which is critical for caspase-3/-7 activation.
(A) Hepatocytes were treated with TNFa (25 ng/ml), ActD (0.4 mg/ml)
or TNFa+ActD and ROS measured by dichlorofluorescin fluorescence
assay and referred to untreated control. (B) ROS accumulation
determined when cells were preincubated with the antioxidant BHA
(100 mM) for 30 minutes before TNFa+ActD treatment. (C) Caspase-3/-7
activation of cells treated with TNFa,T N F a+ActD or both preincubated
with BHA. Values represent means of at least three independent
experiments 6 s.d. (* P,0.001 versus TNFa+ActD+BHA-treated cells,
Student’s t-test).
doi:10.1371/journal.pone.0018646.g002
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genes cFLIP and MnSOD but fails to increase the
respective protein levels
We have shown that TNFa only induced apoptosis in the
presence of the transcription inhibitor ActD. One of the main
antiapoptotic transcription factors which is known to prevent
TNFa-mediated apoptosis is NF-kB. Therefore, we first tested by
EMSA whether NF-kB is activated by TNFa and which dynamics
can be observed. As expected, TNFa leads to an early NF-kB
induction phase in the first 30 minutes followed by a second
induction between 4 and 6 h (Figure 4A). Both NF-kB activation
phases lead to transcriptional upregulation of a variety of target
genes. Among these, several antiapoptotic genes have been
implicated in preventing apoptosis in response to TNFa.
Consequently, we examined the expression of the antiapoptotic
genes cFLIP and MnSOD by qRT-PCR. Whereas MnSOD
mRNA showed a very low induction at 6–8 h, cFLIP revealed a
moderate upregulation 6 h after TNFa treatment. mRNA
upregulation of both genes was completely blocked by ActD
(Figure S1A and S1B). However, Western Blot analysis revealed
that neither MnSOD nor cFLIP protein levels were increased by
TNFa treatment or decreased in response to TNFa and ActD
treatment at the times when caspase-3/-7 activation was observed
(Figures 4B and 4C). This result suggests that besides MnSOD,
other NF-kB target genes might play a more prominent role in
preventing ROS accumulation as it has been suggested before
[27,28]. Interestingly, this finding shows that cFLIP degradation is
not involved in TNFa and ActD-induced apoptosis. However,
several reports indicate that it is crucial in TNFa and
cycloheximide-induced hepatocyte apoptosis [13]. We could
confirm the TNFa and cycloheximide-mediated cFLIP degrada-
tion in our experimental setting (data not shown). These
observations strengthen the role of NF-kB in preventing TNFa-
induced apoptosis and support the idea that, according to the
respective costimulus, different proteins have to be considered
trying to understand this complex apoptosis pathway.
Modeling
Despite the detailed knowledge on individual molecule
interactions underlying TNFa-induced apoptosis, it remains
unclear if these interactions can explain the experimentally
observed overall behavior of the system. Mathematical modeling
is a powerful tool to address the challenges provided by the
complexity of the pathways analyzed in the experiments. The
overall model we present here starts from the recently published
model describing the TNFa and Fas ligand sensitizing effect [20].
First the sensitizing model was enhanced to achieve connection
sites for further interactions. Then an NF-kB model [21] was
appended to deliver mRNA expression. Finally, the loop was
closed backwards to the control of pJNK activity after TNFa
stimulation. Figure 5 shows a scheme of the overall model. The
model is available in the supplementary information (Model S2).
Model S1 shows a diagram of the sensitizing model as presented in
[20]. A scheme of the integrated NF-kB module can be found in
[21]. Simulation results of the overall model are shown in Figure 6
and 7.
Figure 3. Sustained activation of JNK after TNFa plus ActD is ROS-dependent and involved in caspase-3/-7 activation. (A) Western
blot analysis of JNK and phospho-JNK (P-JNK) after treatment with TNFa (25 ng/ml) for the indicated times. (B) JNK and P-JNK levels determined by
Western blot analysis in cells treated with TNFa (25 ng/ml) and ActD (ActD) (0.4 mg/ml) for the indicated times. (C) Analysis of JNK and P-JNK by
Western blot after treatment of hepatocytes with TNFa+ActD with or without preincubation with BHA 100 mM for the indicated times. Actin is used
as loading control. One representative experiment is shown. (D) Caspase-3/-7 activation of cells treated with TNFa+ActD with or without
preincubation with the JNK inhibitor SP600125 20 mM. For comparison, cells were also treated with FasL (50 ng/ml) for 6 hours with or without
costimulation with TNFa+ActD for the indicated times. Means of at least three independent experiments 6 s.d. are shown (# P,0.05 versus
TNFa+ActD-treated cells, Student’s t-test).
doi:10.1371/journal.pone.0018646.g003
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to attach JNK and ROS signaling
The already existing sensitizing model is based on biological
experiments including measurement of caspase-3/-7 activity and
cytochrome c release under varying conditions, such as only
TNFa, only Fas ligand and combination of both, and reproduces
these data [20]. Since this model is used as initial point for the
study presented here we will describe it shortly. The sensitizing
model has two inputs, TNFa and Fas ligand. Active caspase-3 is
considered as output and indication for apoptosis. Fas ligand
activates caspase-8 and thereby also a limited amount of caspase-3
via the direct type I pathway. Caspase-3 is absorbed to a certain
amount by its inhibitor XIAP. In addition, active caspase-8 cleaves
Bid to its active form tBid and thereby activates a certain amount
of Bax/Bak but not enough for mitochondrial membrane
permeabilisation. Therefore, Fas ligand does not induce cyto-
chrome c release from the mitochondria in the sensitizing model
which was shown for cultured primary hepatocytes before [22].
TNFa directly leads to activation of JNK which phosphorylates
Bim, a BH3-only protein in turn also able to activate Bax/Bak.
However, TNFa alone does not activate sufficient amounts of
these proteins to induce cytochrome c release in the sensitizing
model and therefore does not result in any caspase-3 activation. In
addition, Bcl2 is included in the model as an inhibitor for pBim
and tBid. However, if TNFa and Fas ligand pathways crosstalk at
an appropriate time their effects on Bax/Bak turn out to be
additive, cytochrome c is released and a significantly higher
number of caspase-3 is activated. This causes strong apoptosis
which is called the sensitizing effect. As the mechanisms leading to
mitochondrial pore formation and abrupt release of cytochrome c
are not yet known in detail, the release is achieved in the model
using a step function which is triggered at 90% activation of the
Bax/Bak pool. Apart from this step function, the complete model
is based on ODEs and mass action kinetics. The parameters
Figure 4. TNFa induces NF-kB activation but fails to upregulate cFLIP and MnSOD protein. (A) Kinetics of NF-kB-DNA binding activity
measured by EMSA in hepatocytes treated with TNFa (25 ng/ml) for the indicated times. Means of at least three independent experiments 6 s.d. are
shown. cFLIPL/S (B) and MnSOD (C) protein levels determined by Western Blot analysis in primary murine hepatocytes and mouse embryonic
fibroblasts (B, left panel) treated with TNFa (25 ng/ml) with or without ActD (0.4 mg/ml) for the indicated times. Actin is used as loading control. One
representative experiment is shown.
doi:10.1371/journal.pone.0018646.g004
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of concept for the model as it fits the measurement data as well as
current knowledge. Also the initial amounts of the involved
molecular species are unknown and have been set to artificial
numbers. Interestingly, the structure of the sensitizing model
allows also simulating different cell types. TNFa can be enabled to
induce apoptosis by changing initial amounts of proteins which is
equivalent to a different expression pattern.
In the sensitizing model, TNFa directly drives the phosphor-
ylation of JNK. This was sufficient to reproduce the sensitizing
effect which is mainly based on BH3-only protein family members
but is of course a strong simplification. In a first step, we expanded
this area of the model to create connecting points for interaction
with other components of the signaling pathway and allow for
more complex signaling behavior. The TNFa input is now
converting the species complex0 to complex1 (k19) [4]. These
species and also the species complex2 and DISC are modeled in a
simplified manner as one species although they correspond to
multi-protein complexes. The species complex0 is also constitu-
tively produced and degraded to maintain its initial amount in an
unstimulated setting (k43). The Boolean variable actD is explained
below. The species complex1 forms complex2 by recruitment of
FADD (k20) [4] and is also degraded over time (k44). Thereby
complex1 is realized as the main species before complex2 is
formed after TNFa stimulus by k19 =0.05AU{1s{1 and
k20 =0.001AU{1s{1. This is in accordance with JNK signalling
being the main function of TNFa in the model whereas only weak
caspase-8 activation at complex2 occurs after TNFa.
d
dt
complex0(t)~{k19   TNF(t)   complex0(t)zk43 
incomplex0   (1{actD){k43   complex0(t)
d
dt
complex1(t)~k19   TNF(t)   complex0(t){k20 
complex1(t)   FADD(t){k44   complex1(t)
In addition, complex1 activates proMKK7 to MMK7 (k23)[ 9 ] .
Active MKK7 phosphorylates JNK to pJNK (k24) [9]. The pJNK
protein in turn activates a phosphatase (k25) to finally inactivate
MKK7 again (k27) as it has been shown for the p38 regulation
cascade [29]. It is not yet known which phosphatase performs this
task. We assume that the phosphatase recovers to prophosphatase
over time (k26). The dephosphorylation of pJNK is accomplished by
MKPs (k34) [10,30], whose regulation is discussed later on. As these
proteins establish a self terminating mutual activation chain the
model reproduces the disappearance of pJNK after 30 minutes
(Figure 3A and 3B). In addition, the experimentally observed
relation between ROS and the amount of JNK protein is modeled
by a linear relation (k33) as best approximation to our knowledge.
Analysis of Figure 3B reveals an increase of overall JNK after
8 hours by factor 5 after TNFa plus ActD stimulus. Accordingly, the
parameter k33 is set to 2s{1 which results in an increase from 100 to
507 overall JNK species in the model after 8 hours in this scenario.
d
dt
proMKK7(t)~{k23   complex1(t)   proMKK7(t)z
k27   MKK7(t)   phosphatase(t)
d
dt
MKK7(t)~k23   complex1(t)   proMKK7(t){
k27   MKK7(t)   phosphatase(t)
Figure 5. Schema of the mathematical TNFa-induced apoptosis model. Illustration of the model structure in accordance to the model
equations introduced in the Modeling section. Input stimuli of the model are TNFa, Fas ligand, BHA, ActD (actD) and cycloheximide (CHX). The NF-kB
model is depicted as grey box for clarity. The kinetic parameters are indicated to assign the equations to the schema. Production rates are written
into the boxes for the according species. Species which are degraded in the model are framed with dashed lines.
doi:10.1371/journal.pone.0018646.g005
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dt
JNK(t)~{k24   MKK7(t)   JNK(t)zk34 
pJNK(t)   MKP(t)zk33   ROS(t)
d
dt
pJNK(t)~k24   MKK7(t)   JNK(t){k34 
pJNK(t)   MKP(t)
d
dt
prophosphatase(t)~{k25   prophosphatase(t) 
pJNK(t)zk26   phosphatase(t)
d
dt
phosphatase(t)~k25   prophosphatase(t) 
pJNK(t){k26   phosphatase(t)
Due to these changes in the model the parameters k1 and k2 from
the sensitizing model dropped out. These are the only structural
changes of the original model we made during the integration
process. Moreover, the initial values for all species remain
unchanged. Only the parameters k5,k7,k9,k11,k12 are newly fitted
as shown in the supplementary information (Model S1) to maintain
properreproductionofthe sensitizingeffectinsidethenew,extended
model framework. Additionally, the threshold of Bax/Bak activation
for mitochondrial pore formation was lowered from 90% to 20% as
this process is now more tightly regulated in the extended model.
This is in accordance with a recent study suggesting an only weak
increase of Bax in the mitochondria before pore formation [31].
In the sensitizing model, TNFa and Fas ligand signals do not
crosstalk upstream from Bax/Bak. This is now adjusted, since
caspase-8 is not only activated by Fas ligand via the DISC (k22) but
also at complex2 after TNFa (k21) [4]. Active caspase-8 is also
degraded over time (k8). Due to these changes in the model the
parameter k7 from the sensitizing model dropped out. The
influence of Fas ligand is now modeled as activating the formation
of the DISC from species subsumed as proDISC and recruiting
FADD (k47). Thereby FADD is a common pool for complex2 and
DISC formation.
d
dt
FADD(t)~{k20   complex1(t)   FADD(t){
k47   Fas(t)   proDISC(t)   FADD(t)
Figure 6. Simulation results of the TNFa-induced apoptosis model after TNFa, TNFa plus ActD and TNFa/Fas ligand sensitizing.
Simulation results for pivotal species of the TNFa-induced apoptosis model after stimulation with TNFa only (A–C), with TNFa plus ActD (D–F) over
10 hours or after TNFa/Fas ligand sensitizing (12 h TNFa preincubation before Fas stimulus) (G–I) over 20 hours. The species are shown in separate
panels for clarity as indicated in the legend.
doi:10.1371/journal.pone.0018646.g006
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dt
proDISC(t)~{k47   Fas(t)   proDISC(t)   FADD(t)
d
dt
C8(t)~{k21   complex2(t)   C8(t){k22   DISC(t)   C8(t)
d
dt
C8a(t)~k21   complex2(t)   C8(t)zk22 
DISC(t)   C8(t){k8   C8a(t)
The activation of caspase-8 at complex2 as well as at the DISC is
competitively inhibited by cFLIP whose main type in murine
hepatocytes is the long form according to our experimental results.
The species cFLIP binds complex2 in a complex named c2FLIP in
the model (k39) and binds DISC in a complex named DcFLIP in
the model (k40) [14]. These complexes are also dissociating to their
components again (k41 and k42). Finally, complex2 and DISC are
degraded (k45 and k46).
d
dt
complex2(t)~k20   complex1(t)   FADD(t){k39 
complex2(t)   cFLIP(t)zk41   c2FLIP(t){
k45   complex2(t)
d
dt
DISC(t)~{k40   DISC(t)   cFLIP(t)zk42 
DcFLIP(t){k46   DISC(t)z
k47   Fas(t)   proDISC(t)   FADD(t)
d
dt
c2FLIP(t)~k39   complex2(t)   cFLIP(t){k41   c2FLIP(t)
d
dt
DcFLIP(t)~k40   DISC(t)   cFLIP(t){k42   DcFLIP(t)
The amount of free cFLIP species in the model can be regulated
by several influences. It is affected by c2FLIP and DcFLIP
formation. According to our results in primary murine hepato-
cytes, the amount of cFLIP protein is stable after TNFa plus ActD
treatment. This result indicates that the cFLIP protein is not
degraded or produced from mRNA in the considered time frame
under the according experimental conditions. However, cFLIP
was reported to be degraded by the enzyme Itch (k38) when cells
were treated with TNFa plus cycloheximide [13].
d
dt
cFLIP(t)~{k38   cFLIP(t)   itchPPP(t){k39 
complex2(t)   cFLIP(t){k40   DISC(t) 
cFLIP(t)zk41   c2FLIP(t)zk42   DcFLIP(t)
The activation of Itch has been reported to be driven by pJNK,
where several phosphorylations are required (k35,k36,k37). We
assume three times phosphorylated Itch (itchPPP) as active
species as supposed in [32]. Itch can function as an integrator
for pJNK. As illustrated in Figure 7A the catenation of several
steps allows for a decoupling of the curve shapes of pJNK and
itchPPP. To achieve this effect the kinetic parameters for the
successive phosphorylation steps need to be increasing which
is consistent with a biological cooperativity effect. The values
have been chosen as k35~0:015AU{1s{1, k36~0:025AU{1s{1
and k37~0:045AU{1s{1. As Itch was shown to be a highly stable
protein [33] the model does not include Itch degradation. Overall,
Itch couples JNK activation to cFLIP in the model which was
shown as principle mechanism after TNFa plus cycloheximide
treatment [13]. As this Itch-mediated cFLIP degradation does not
occur after TNFa plus ActD treatment the model discriminates
between ActD and cycloheximide. Itch can only be phosphory-
lated and activated in the presence of cycloheximide represented
by a Boolean variable named CHX. Without cycloheximide the
proapoptotic impact of pJNK in the model is exerted solely via
phosphorylation of Bim as modelled in [20].
Figure 7. Simulation results of the TNFa-induced apoptosis
model after TNFa plus cycloheximide. (A–C) Simulation results for
pivotal species of the TNFa-induced apoptosis model over 10 hours
after stimulation with TNFa plus cycloheximide. The amount of pJNK is
reduced to one third for this Figure. The species are shown in separate
panels for clarity as indicated in the legend.
doi:10.1371/journal.pone.0018646.g007
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dt
itch(t)~{k35   CHX   itch(t)   pJNK(t)
d
dt
itchP(t)~k35   CHX   itch(t)   pJNK(t){
k36   itchP(t)   pJNK(t)
d
dt
itchPP(t)~k36   itchP(t)   pJNK(t){
k37   itchPP(t)   pJNK(t)
d
dt
itchPPP(t)~k37   itchPP(t)   pJNK(t)
An NF-kB model is attached to the TNFa input signal
An NF-kB model is included as module in the TNFa
signaling pathway model to allow description of transcriptional
effects on the network. We used the NF-kB model from
Lipniacki et al. [21] because of its high grade of accuracy. The
model provides a detailed description of NF-kB activation in
response to TNFa and delivers the resulting mRNA production.
It includes the proteins NF-kB, IKK, IkBa, A20 and several
complexes of them as well as transcripts of A20, IkBa and an
additional exemplary target gene of NF-kB. Cytoplasm and
nucleus are modeled as separate compartments. Regarding the
initial amounts of proteins and mRNA species Lipniacki et al.
used several previous studies which measured components of the
NF-kB signaling pathway in absolute units. The model
equations contain 30 parameters from which 5 are taken from
the literature, 13 are assumed, 10 were fitted and the value of 2
parameters turned out to be insignificant. Using these param-
eters the model reproduces oscillations of unbound nuclear NF-
kB proteins and the related species which is considered to be
typical for this biological system. The model is adopted here
with very few changes that are described in the following
section.
Notation for parameters and species is retained unchanged
from Lipniacki et al. for better comparability. The input of the
NF-kB model is realized by Lipniacki et al. with a logical variable
named Tr [21]. This is maintained by setting Tr to ‘‘1’’ if the cell
is stimulated with TNFa and to ‘‘0’’ if not. We newly introduce a
logical variable for gene expression to realize the impact of
transcription inhibitor ActD in this module. This variable is
named actD and is set to ‘‘1’’ in presence and set to ‘‘0’’ in
absence of ActD. The modeling of ActD without interstages is
based on our experimental setting because ActD is added 30 min
prior to TNFa stimulation. The latter is equivalent to time point
zero in the model because transcription is already completely
stopped at the beginning of stimulation. By introducing ActD the
following equations of the model from Lipniacki et al. [21] are
changed so that there is not any transcript production in the
presence of ActD.
d
dt
IKKn(t)~kprod   (1{actD){kdegIKKn(t){TRk1IKKn(t)
d
dt
A20t(t)~c2   (1{actD)zc1NFkBn(t) 
(1{actD){c3A20t(t)
d
dt
IkBat(t)~c2a   (1{actD)zc1aNFkBn(t) 
(1{actD){c3aIkBat(t)
All other equations and parameter values of the NF-kB model
remained with a single exception. We assume the relation of
cytoplasmic to nuclear volume in hepatocytes to have value 3
instead of 5 as used for fibroblasts by Lipniacki et al. [21]. In
addition, as the original time unit in the Lipniacki model are
seconds, all parameter values are multiplied with 3600 to achieve
hours as consistent unit in the overall model. As initial values of
the state variables their steady state values from unstimulated
model simulation is calculated.
The output of the NF-kB model from Lipniacki et al. is an
unspecified exemplary NF-kB target gene [21]. We use the
according equation to model the mRNA for a protein P.
d
dt
PmRNA(t)~c1c   NFkBn(t)   (1{actD){c2cPmRNA(t)
The parameter values regarding regulation of the transcripts are
changed in comparison with the target gene from Lipniacki et al. to
fit our measurement data. We applied an iterative manual fitting
approach as also described by Lipniacki et al. [21]. The parameter
c1c describes inducible mRNA synthesis and is fitted to the
measurement data as 5   10{7AUs{1. As only the amount of
ROS released in addition after TNFa and not constitutively
produced ROS is considered, accordingly only the amount of its
counterpart P additionally induced via NF-kB is respected. By
setting the variable actD to zero the model can reproduce the fact
that mRNA synthesis is completely blocked in the presence of
ActD (Figure 5 and S1). The parameter c2c describes mRNA
degradation and is set to 10{4s{1. The translation rate k28 from
mRNA to protein is set to 25 AU{1s{1.
Note that there is no NF-kB activation after Fas ligand in the
model. This is in accordance to previous experimental findings in
primary mouse hepatocytes which showed that there is only weak
NF-kB activation and no induction of the NF-kB target genes such
as cFLIP and cIAP2 in response to FasL [34].
The regulation of ROS rules the network by controlling
the amount of phosphorylated JNK
ROS can be judged as central players of the network. We will
first discuss their origin and regulation and afterwards their effects.
The origin of ROS due to TNFa stimulation are the mitochondria
[35,36]. We assume that the constitutively produced amount of
ROS in the cell is not responsible for their effects after TNFa
stimulation. Therefore, we decided to model only the additional
amounts of ROS in this setting. Accordingly the initial value of
ROS in the model is 0. This also suits our experimental approach
measuring the total amounts of ROS in hepatocytes referred to
untreated control. The data show that ROS accumulate after
4 hours and remain constant after 5 hours (Figure 2A). Recently, a
mathematical reaction-diffusion model of ROS-induced ROS
release was presented [37]. It demonstrates how ROS release
could be realized in short period. However, it is not known how
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cytochrome c release. We modeled the disposal of ROS in
response to TNFa stimulus using the variable Tr and a function
with a narrow peak at 4 hours representing the release of 100 units
of ROS. If this burst happens and the amount of ROS cannot
anymore be neutralized by a scavenger protein P or fully react
with MKPs, remaining ROS persist in the cytoplasm at a high
level in our simulations (Figure 6C,D) as shown experimentally
(Figure 2A,B). In our experiments the antioxidant BHA is used
which is known as potent ROS scavenger. As we could show that
BHA completely abolishes the occurrence of ROS in the cell
(Figure 2B), we realized its impact with a logical variable set to ‘‘1’’
if BHA is present and set to ‘‘0’’ if BHA is not present.
ROSfree(t)~
1
s
ﬃﬃﬃﬃﬃﬃ
2p
p exp {
1
2
t{m
s
   2   
  100   (1{BHA)   Tr
The NF-kB module delivers P mRNA which is translated to the P
protein (k28). If ROS is released, its amount is buffered by P protein
(k30). The parameter k30 is set to 1 AU{1s{1 to neutralize ROS
after TNFa stimulation fast enough to repress further effects. This
scavenging mechanism explains the observation that only the
combination of TNFa plus ActD leads to a significant increase in
intracellular ROS amounts (Figure 2A). After ActD treatment P
mRNAisnolongersynthesizedand thereforeROSisnot scavenged
and can display its impact.
d
dt
P(t)~k28   PmRNA(t){k30   P(t)   ROS(t)
The effect of ROS on the network will now close the loop to the
upstream effects of TNFa. As mentioned above, MKPs dephos-
phorylate pJNK. MKPs themselves canbe oxidized and are thereby
inactivated by ROS (k31) [10]. There is also a backward reaction to
this oxidation (k32).
d
dt
MKP(t)~{k31   ROS(t)   MKP(t)zk32   MKPox(t)
d
dt
MKPox(t)~k31   ROS(t)   MKP(t){k32   MKPox(t)
Finally, we give the equation for ROS which are buffered by P (k30)
and consumed by the oxidation of MKPs (k31).
d
dt
ROS(t)~ROSfree(t){k30   P(t)   ROS(t){
k31   ROS(t)   MKP(t)
Summarized, ROS can increase the amount of pJNK via two
different routes. The oxidation of MKPs via ROS after ActD
removesthedephosphorylationmechanismsforpJNK.Therebythe
regulative loop consisting of MKPs, pJNK, MKK7 and its
phosphatase, is broken. Additionally, our experiments revealed a
correlation between ROS and highly increased amounts of
unphosphorylated JNK. Via these two mechanisms strong and
sustained pJNK activation is established after ROS release in the
model reflecting our experimental results (Figure 3B).
Parameterization of the model in accordance with a
complex requirement profile
The initial values of the species from the sensitizing model [20]
and from the NF-kB model [21] are maintained. As their absolute
amount is not known the initial values of the species DISC, cFLIP,
complex0, JNK, proMKK7, Itch and prophosphatase are set to
100% according to [20]. The initial amount of MKP protein is
50% which was set in relation to 100% JNK and ROS,
respectively. The initial amount of FADD was set to 200% as it
represents a common pool for complex2 and DISC assembly but
there is no hint on competitive behavior of these two processes to
our knowledge. All other species have initial value zero.
The reaction parameters for the model extension are fitted using
a manually iterative approach as proposed in [21] and are listed in
Table 1. The goal of the parameter fitting was to fulfill the
following qualitative overall constraints in accordance to our
experimental results in murine hepatocytes. The model has to
show no caspase-3 activation after TNFa, medium caspase-3
activation after Fas ligand and high caspase-3 activation after
TNFa/Fas ligand sensitizing as shown in [20] for wildtype
hepatocytes. In addition, it was shown that the stronger apoptosis
in XIAP knockout mice after Fas ligand is not further enhanced by
the sensitizing effect [20]. The experimental results in this study
request the model to reproduce high caspase-3 activation in
wildtype cells after TNFa plus ActD treatment but not any
caspase-3 activation if BHA is added to this experimental setting.
Moreover, it was shown that TNFa plus ActD treatment does not
induce apoptosis to a remarkable extent in Bid knockout mice
[22].
To conform to these requirements the different routes to
caspase-3 activation need to be in a precise balance which is
established to a large extent by the parameterization of the
equations in connection with the species cFLIP. The parameter
k22 for the activation of caspase-8 at the DISC was set to 0.8
AU{1s{1. As it was shown that cFLIP is bound preferentially to
caspase-8 at the DISC [38] the parameter k40 for the inhibition of
caspase-8 activation at the DISC by cFLIP is defined to be 8
AU{1s{1 thereby also guaranteeing the apoptotic threshold
realized by cFLIP [39]. The same factor is assumed for the
competition of caspase-8 and cFLIP at complex2 (k21, k39) but the
activation of caspase-8 in the model is ten times lower at complex2
than at the DISC. This parameterization guarantees that Fas
ligand is activating sufficient caspase-3 in the model to overcome
the XIAP buffer but not inducing cytochrome c release and TNFa
does not lead to significant caspase-3 activation. However, TNFa
activates sufficient caspase-8 via complex2 to cleave some Bid
molecules. The increased levels of pJNK after TNFa plus ActD
treatment phosphorylate the complete pool of Bim and thereby
exhaust the Bcl2 buffer in the model. However, TNFa plus ActD
treatment does not lead to enhanced apoptosis in hepatocytes from
Bid knockout mice [22]. Therefore, an equivalent amount of Bim
and Bcl2 is modeled and an additional apoptotic impact of TNFa
via caspase-8 and tBid is necessary.
A critical point is also the regulation of JNK phosphorylation
after TNFa and ActD. The according parameters are set to be
k24 =0.4 AU{1s{1 for the phosphorylation of JNK by MKK7
and k34 =0.9 AU{1s{1 for the even faster dephosphorylation of
pJNK by MKPs. These parameters allow for rapid adjustment of
the balance between JNK and pJNK in reaction to signals but also
guarantee a quick termination of the pJNK signal. Thereby the
measurements showing pJNK appearing in a first rapid and very
short peak which is terminated abruptly can be reproduced. The
termination of the first peak needs active MKPs and follows the
downregulation of MKK7 via the according active phosphatase
induced by pJNK itself. However, some MKK7 proteins still need
to be active at later time points to induce the second activation
phase of JNK. Therefore, the balance between prophosphatase,
phosphatase, complex0, complex1, complex2 and MKK7 is
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oxidizing MKPs efficiently (k31 =0.1 AU{1s{1) which in turn
recover slowly (k32 =0.01 AU{1s{1). Additionally, ROS is related
to a strongly increased amount of JNK. Overall ten different
species are now involved in JNK regulation in the model in
contrast to a single species in the sensitizing model [20].
In Supplementary Information S1, we provide local sensitivity
coefficients of pJNK, activated Bax/Bak and activated C3 with
respect to the model parameters after stimulation with TNF.
These coefficients show to which extent the single parameters push
the system to survival or apoptosis. We further provide a
robustness analysis, where we test to which degree single
parameters can be disturbed without changing the apoptosis/
survival pattern in the wildtype after different stimulations.
Parameters of processes that robustly lead to apoptosis (e.g. the
formation of DISC complex 2) can be varied by four orders of
magnitude without influencing the decision of survival versus
apoptosis. Parameters describing important control points at the
complex 1 and 2, the Bim/Bid module, the phosphorylation of
JNK and the the NF-kB module show a much less robust
behaviour.
The modeled interplay of species successfully reproduces
the measurement data
Figure 6 shows simulation results for TNFa stimulation (A–C),
for TNFa plus ActD stimulation (D–F) and simulations of the
TNFa/Fas ligand sensitizing effect (G–I). After TNFa stimulation
there is only one peak of JNK activation at around 30 min which
is terminated by MKPs in between 60 min (6C). This activation is
not sufficient to phosphorylate a significant amount of Bim (6B).
ROS are released after four hours (6C); however, they are
neutralized by protein P which was induced by TNFa activating
the NF-kB module (6A). In contrast, high ROS levels remain in
the cell (6D) and oxidize MKPs (6F) after concomitant treatment
with TNFa and ActD because P is not produced. ROS induce a
strong increase in the amount of JNK (6F). For these two reasons,
a second activation of JNK occurs which is not only longer lasting
but also at a far higher level (6F). In addition, there is weak
activation of caspase-8 at complex2 (6E). The produced protein
forms tBid and pBim lead to exhaustion of the Bcl2 buffer and
finally to cytochrome c release mediated by active Bax/Bak (6E).
Thereby caspase-3 is activated to the maximally possible amount
in the model which is restricted in wildtype cells by the presence of
XIAP. Finally, the model is used to simulate the sensitizing effect.
Equivalently to the experimental conditions, TNFa is given as
model input from time point zero and after 12 hours Fas stimulus
is added. For the first 12 hours the simulation is identical with
TNFa only. After Fas ligand is added at 12 hours there is strong
activation of caspase-8 at the DISC and also tBid is produced
which finally leads to cytochrome c release (6H). Caspase-3 is
activated in this scenario by active caspase-8 directly as well as by
cytochrome c. However, caspase-3 is not activated to a higher
extent as after TNFa plus ActD treatment. The reason is that
cytochrome c is released in both scenarios and its strong impact
covers the additional direct caspase-3 activation by caspase-8.
The simulations after concomitant treatment with TNFa, ActD
and BHA are shown in Figure S2. There is no ROS release due to
BHA, accordingly MKPs remain and a second pJNK increase is
missing in the model which is in agreement with our experimental
results (Figure 3C). Consequently, caspase-3 is not activated as it is
shown experimentally in Figure 2C.
Simulations of the model after treatment with TNFa plus
cycloheximide are shown in Figure 7. The amount of JNK and
pJNK is increased in this setting as described above for TNFa plus
ActD. In the presence of cycloheximide pJNK additionally
phosphorylates Itch (7A). The threefold phosphorylated form of
Itch degrades cFLIP and thereby a high amount of caspase-8 is
activated in this scenario (7C). However, the model does not
predict a difference in caspase-3 activity whether TNFa is
combined with ActD or with cycloheximide as again the scenario
is determined by 100% cytochrome c release.
Table 1. Parameter values for the extended TNFa-induced
apoptosis model.
parameter value unit character of interaction
k19 0:05 AU{1s{1 assembly of complex1
k20 0:001 AU{1s{1 assembly of complex2
k21 0:08 AU{1s{1 activation of caspase-8 at
complex2
k22 0:8 AU{1s{1 activation of caspase-8
at the DISC
k23 0:05 AU{1s{1 activation of MKK7
by complex1
k24 0:4 AU{1s{1 phosphorylation
of JNK by MKK7
k25 0:05 AU{1s{1 activation of prophosphatase
by pJNK
k26 0:05 s{1 decay of active phosphatase
k27 2 AU{1s{1 dephosphorylation of
MKK7 by phosphatase
k28 25   3600 s{1 translation of protein P
k30 1 AU{1s{1 absorption of
ROS by protein P
k31 0:1 AU{1s{1 oxidation of MKPs by ROS
k32 0:01 s{1 recovering of oxidized MKPs
k33 2 s{1 linear increase of the amount
of JNK in relation to ROS
k34 0:9 AU{1s{1 dephosphorylation
of pJNK by MKPs
k35 0:015 AU{1s{1 phosphorylation of itch by
pJNK in presence of CHX
k36 0:025 AU{1s{1 phosphorylation
of itchP by pJNK
k37 0:045 AU{1s{1 phosphorylation
of itchPP by pJNK
k38 0:05 AU{1s{1 degradation of cFLIP by itchPPP
k39 0:8 AU{1s{1 inhibition of
complex2 by cFLIP
k40 8 AU{1s{1 inhibition of DISC by cFLIP
k41 0:008 s{1 decay of complex c2FLIP
k42 0:008 s{1 decay of complex DcFLIP
k43 0:001 s{1 turnover of complex0
k44 0:05 s{1 decay of complex1
k45 0:05 s{1 decay of complex2
k46 0:05 s{1 decay of the DISC
k47 0:005 AU{2s{1 assembly of the DISC
Parameter identifiers k1{k18 have been used in [20] and are listed in the
supplementary information (Model S1). As this is a qualitative model the
parameter values are not identical with kinetic constants at the level of
elementary reactions and are declared in artificial units (AU).
doi:10.1371/journal.pone.0018646.t001
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Using ordinary differential equation (ODE) models is a standard
approach in systems biology as it allows describing dynamic
behavior over time. A drawback of this approach is however the
dependency on kinetic parameters for the simulation of an ODE
model. For biological interactions, these parameters usually cannot
be directly measured and need to be identified from measurement
data. These data are most often not quantitative in absolute units
and is afflicted with uncertainty. In addition, many model
parameters are in fact not elementary biochemical parameters
but subsume several processes which are not modelled in detail.
This might be one of the reasons that ODE models for biological
systems are rarely merged into larger models although a variety of
signalling pathway models is already available. There are
supporting approaches to technically merge mathematical models
[40]. However, model integration is a complex task as different
mathematical models usually do not adhere to a common
modeling standard.
We extended an existing model of TNFa and FasL sensitizing
by adding the regulation of pJNK and its impact on the signaling
network. Thereby ROS signaling and a published NF-kB model
were integrated in the framework. The presented mathematical
model is based on biological experiments and on literature.
Overall the model comprises 53 different species (thereof 16 in the
NF-kB module) and 74 reaction parameters.
The presented extended model still reproduces the sensitizing
effect which was a presupposed quality requirement. During the
integration of the sensitizing model into the far bigger framework
we present here, overall seven parameters from the originally
published model have been changed. JNK is now activated in a
peak-like fashion which is in accordance with our measurement
results (Fig. 3). Due to the adjusted parameterization of the model
Bax/Bak is now not activated at all after a sole TNFa or Fas ligand
stimulation. As a certain level of active Bax/Bak can finally lead to
cytochrome c release, the more well-defined difference between
not any and high Bax/Bak activation is equivalent with a more
stable type I apoptosis in the model. Overall the reproduction of
the sensitizing effect is not only maintained but even improved.
Moreover, the presented expanded model for TNFa-induced
apoptosis now also reproduces apoptosis after combined TNFa
and ActD treatment as well as the effect of BHA. The qualitative
interactions in the network are based on literature data and the
presented measurement data for murine hepatocytes which clearly
document the modeled functional mechanisms.
In this work, a special focus lies on the intention to analyze
several pathways that have been associated with TNFa-induced
apoptosis but measured rather separately. Although knowledge
exists on the regulation and implication of JNK [41], the crosstalk
of JNK and NF-kB [8] and the relevance of ROS accumulation
and JNK prolongation [32], the overall analyses of these pathways
in one cell type is still rare. Experimental data have been reported
for each single of these processes in several cell types but the
interplay of JNK, NF-kB and ROS has been shown here in more
detail in primary murine hepatocytes. In this context, it is also
known that TNFa such as other death receptor ligands can trigger
either type I or type II apoptosis pathway [42], and that very
different regulation signals are involved in both. Having
demonstrated that TNFa activates type II apoptosis signaling,
this pathway could in this work be further linked to the JNK, ROS
and NF-kB pathways in hepatocytes.
In particular, it could be shown that TNFa plus ActD induce
apoptosis by ROS-mediated sustained activation of JNK.
Furthermore, the inactivation of NF-kB-mediated survival gene
transcription was shown to be critically involved as it has been
reported before [17,43]. Because ROS is supposed to act upstream
of JNK, inhibition of ROS accumulation by NF-kB is assumed to
be one major regulatory step [44]. ROS can be neutralized by
superoxide dismutases (SODs). Especially MnSOD has been
shown to be upregulated by NF-kB and to suppress TNFa-
mediated ROS accumulation and cell death in MEFs and cancer
cells [10,45]. However, we could not confirm any MnSOD
upregulation in response to TNFa treatment nor the reduction of
MnSOD protein in response to TNFa plus ActD treatment. Thus,
other NF-kB-dependent mechanisms seem to control the ROS-
mediated activation of JNK in primary murine hepatocytes.
Interestingly, NF-kB induces the expression of ferritin heavy chain
(FHC), which binds and stores iron ions which reduce ROS levels
and inhibit prolonged JNK activation [28]. Several other NF-kB
target genes have been associated with inhibition of the JNK
signal, namely Gadd45b, which inhibits JNK by blocking the
catalytic activity of MKK7 [27], XIAP [43] and A20 [46]. Taken
together, the NF-kB-mediated control of ROS and JNK seems to
be composed of several regulatory proteins and has to be
determined for each cell type specifically.
In this work we report the unexpected finding that ROS
upregulate the levels of JNK protein and that this upregulation
might be the reason for an increase in phosphorylated JNK.
Moreover, first experiments in primary murine hepatocytes
suggest that this ROS-mediated JNK upregulation might be
controlled by JNK itself because inhibition of JNK activity
abrogates the reported increase in JNK protein levels (data not
shown). However, this regulatory step should be investigated in
more detail in order to understand the exact mechanisms involved.
Astonishingly, one of the major regulators of caspase-8
activation, cFLIP, which has been shown to be degraded in
TNFa-mediated apoptosis [13] remained unchanged upon TNFa
plus ActD treatment in our experiments. However, Chang et al.
demonstrated cFLIP degradation in response to TNFa plus
cycloheximide which we could reproduce in murine hepatocytes
(data not shown). Accordingly, it can be suggested that the
apoptosis pathway induced by TNFa plus ActD differs from the
mechanism via the JNK and Itch-mediated cFLIP degradation
and predominantly caspase-8 activation induced by TNFa plus
cycloheximide as shown by Chang et al [13]. Interestingly, TNFa
has recently been reported to induce two distinct caspase-8
dependent apoptosis pathways [47]. In this study, Wang et al.
demonstrated that autodegradation of cIAPs by smac mimetics
triggers the formation of a new caspase-8 activating complex while
TNFa and cycloheximide induce caspase-8 activation via cFLIP
degradation and complex II formation. Thus, it could be
speculated that this TNFa-Smac mimetic-mediated apoptosis
pathway may be similar to the one observed in response to TNFa
plus ActD treatment.
In our model we assume TNFa plus ActD to predominantly act
by the ROS-mediated strong and sustained activation of JNK
which results in the generation of pBim [20,48]. Large amounts of
pBim cooperate with tBid to finally activate the mitochondrial
pathway and result in cytochrome c release. This finding has been
shown to be even true in-vivo in the case of fatal hepatitis and
seems to be of general relevance in the control of hepatocyte
apoptosis during liver disease [16,49].
The experimental approach together with the extended model
provides a deep and more complete insight in TNF signaling in
murine hepatocytes. There are further participating interactions
that are currently not included in the model. For example, XIAP
and MKPs are known NF-kB target genes, too [43]. This could
exert at least a quantitative influence in the analyzed setting.
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network is able to reproduce the measurement data.
It is sometimes not so difficult to model a certain qualitative
behavior with a very simple, reduced model while neglecting the
connections and crosstalks of the modeled species in the signaling
framework of the cell. In the case of NF-kB a lot of effort has been
put in mathematical modeling in order to understand the
dynamics of this pathway (reviewed in [50]). However, many
models focus on isolated steps of the signaling such as e.g. IKK
dephosphorylation [51]. The TNF receptor has been employed to
trigger mathematical NF-kB models in these studies [52,53] but no
other signaling pathways have been included. Cho et al. take the
amount of FADD complex as indicator for apoptosis in their NF-
kB model but without modeling e.g. caspases [54]. There are
several models dealing with caspase activation and inhibition in
type I apoptosis [55] or type II apoptosis [56–60]. However, these
models also in turn do not comprehend NF-kB or other
crosstalking signaling pathways. If any receptor species is used
these models also include either TNFR [60] or Fas/CD95 [57,59].
Examples for more comprehensive models include a model of
TRAIL-induced apoptosis with detailed mitochondrial module
[61], a model of CD95L-induced apoptosis with highly detailed
caspase module [39] and a model of TNFa-induced apoptosis with
a simple NF-kB module [62]. All these models provide valuable
insights into their respective signaling pathway. However, they
originally cannot reflect behavior patterns which emerge from the
crosstalk between different pathways as we present them in this
study.
Systems biology just started to pass on from dynamic modeling
of single pathways to dynamic modeling of comprehensive and
intensively crosslinked networks. More information can be gained
by adding further levels of detail in existing models [50,63,64].
Here, we provide a first framework that helps to explain the
complex interactions between TNFa signaling, Fas signaling and
transcriptional activity. We intend to give a motivating example
for integration of several dynamical mathematical models into a
holistic model describing complex crosstalk. The presented model
can be used for integration of even more models in the context of
the apoptosis/survival switch to finally improve the analysis of all
involved pathways and the understanding of the holistic network.
As especially the Bcl-2 family and NF-kB are central network hubs
in the cell there are many signaling pathways which have
connecting points with the model presented here. They could all
be mathematically modeled and integrated to analyze their impact
on apoptosis but also the influence of apoptotic signaling to them.
The extensive cross-linking of dependencies can thereby lead
towards a stepwise improvement of the network model as every
additional player restricts degrees of freedom for others.
Supporting Information
Figure S1 cFLIP and MnSOD mRNA are moderately
upregulated by TNFa while ActD treatment abrogates
their expression. Primary murine hepatocytes were treated
with TNFa (25 ng/ml) with or without ActD (0.4 mg/ml) for the
indicated times and cFLIP (A) and MnSOD (B) mRNA levels
determined by qRT-PCR. Means of at least three independent
experiments 6 s.d. are shown.
(TIF)
Figure S2 Simulation results of the TNFa-induced
apoptosis model after TNFa, ActD and BHA. (A–C)
Simulation results for pivotal species of the TNFa-induced
apoptosis model over 10 hours after concomitant stimulation with
TNFa, ActD and BHA. The species are shown in separate panels
for clarity as indicated in the legend.
(TIF)
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containing the model.
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